Newsletter subscription & archive
Biopeople

CytoVac A/S

Cytovac is a growing Danish biotech company, focusing on development of a cancer treatment that uses the body’s own immune system.

Promising results gained by the dedicated research team over a number of years, have brought about the development of the ALECSAT therapy. ALECSAT is a therapy based on injection of activated cells from the immune system.

CloseClose
What are you looking for?
By using this website, you agree to the use of cookies to give you the best user experience.
Find additional information at Cookies
Ok